Pages that link to "Q69383305"
Jump to navigation
Jump to search
The following pages link to Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP (Q69383305):
Displaying 24 items.
- Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases (Q34599923) (← links)
- Purification and subunit composition of atrial natriuretic peptide receptor (Q34604568) (← links)
- Specific binding of atrial natriuretic factor in brain microvessels (Q34610755) (← links)
- Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. (Q35579032) (← links)
- Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction (Q36816167) (← links)
- Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats (Q40378674) (← links)
- Characterization and regulation of atrial natriuretic peptide (ANP)-R1 receptors in the human neuroblastoma cell line NB-OK-1. (Q41683668) (← links)
- Phorbol and calcium decreased atriopeptin response in a human renal cell line (Q41694541) (← links)
- Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation (Q41939200) (← links)
- A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro. (Q42086145) (← links)
- Actions of atrial natriuretic peptide (ANP) on cyclic nucleotide concentrations and phosphatidylinositol turnover in ventricular myocytes (Q42488487) (← links)
- An activator of protein kinase C (phorbol dibutyrate) attenuates atrial-natriuretic-factor-stimulated cyclic GMP accumulation in smooth-muscle cells (Q42500978) (← links)
- Heterologous down-regulation of vascular atrial natriuretic peptide receptors by phorbol esters (Q42501849) (← links)
- Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. (Q53998579) (← links)
- Atrial natriuretic peptide in liver cirrhosis with mild ascites (Q68464822) (← links)
- Phosphorylation of high- and low-molecular-mass atrial natriuretic peptide analogs by cyclic AMP-dependent protein kinase (Q69814147) (← links)
- Design and synthesis of metabolically stable atrial natriuretic factor analogs. Amino- and carboxy-terminal stabilization (Q69838514) (← links)
- Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure (Q70046494) (← links)
- Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation (Q70058348) (← links)
- Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes (Q70178037) (← links)
- In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans (Q71893350) (← links)
- Basal nitric oxide synthesis in essential hypertension (Q73273898) (← links)
- Measurement of nitric oxide synthesis in humans using L-[15N2]arginine (Q77907985) (← links)
- Atrial natriuretic peptide and angiotensin II binding sites in cerebral capillaries of spontaneously hypertensive rats (Q93513433) (← links)